Literature DB >> 2686884

The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part II).

W L Chiou1.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2686884     DOI： 10.2165/00003088-198917040-00005

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  148 in total

1.  Concentrations of ethanol in two segments of the vascular system.

Authors:  A J Sedman; P K Wilkinson; J G Wagner
Journal:  J Forensic Sci       Date:  1976-04       Impact factor: 1.832

2.  Effects of arterial versus venous sampling on analysis of glucose kinetics in man.

Authors:  E A McGuire; J H Helderman; J D Tobin; R Andres; M Berman
Journal:  J Appl Physiol       Date:  1976-10       Impact factor: 3.531

3.  Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment.

Authors:  S Riegelman; J C Loo; M Rowland
Journal:  J Pharm Sci       Date:  1968-01       Impact factor: 3.534

4.  Rapid compartment- and model-independent estimation of times required to attain various fractions of steady-state plasma level during multiple dosing of drugs obeying superposition principle and having various absorption or infusion kinetics.

Authors:  W L Chiou
Journal:  J Pharm Sci       Date:  1979-12       Impact factor: 3.534

5.  Method for the rapid estimation of the total body drug clearance and adjustment of dosage regimens in patients during a constant-rate intravenous infusion.

Authors:  W L Chiou; M A Gadalla; G W Peng
Journal:  J Pharmacokinet Biopharm       Date:  1978-04

Review 6.  Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models.

Authors:  N H Holford; L B Sheiner
Journal:  Clin Pharmacokinet       Date:  1981 Nov-Dec       Impact factor: 6.447

7.  Arterial-venous differences of plasma catecholamines in man.

Authors:  J B Halter; A E Pflug; A G Tolas
Journal:  Metabolism       Date:  1980-01       Impact factor: 8.694

8.  Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level--time curve.

Authors:  W L Chiou
Journal:  J Pharmacokinet Biopharm       Date:  1978-12

9.  Degradation of porstaglandin F2alpha in the human pulmonary circulation.

Authors:  P Jose; U Niederhauser; P J Piper; C Robinson; A P Smith
Journal:  Thorax       Date:  1976-12       Impact factor: 9.139

10.  Pharmacodynamic modeling of thiopental anesthesia.

Authors:  D R Stanski; R J Hudson; T D Homer; L J Saidman; E Meathe
Journal:  J Pharmacokinet Biopharm       Date:  1984-04
View more
  35 in total

1.  Do plasma concentrations obtained from early arterial blood sampling improve pharmacokinetic/pharmacodynamic modeling?

Authors:  T M Beaufort; J H Proost; K Kuizenga; M C Houwertjes; U W Kleef; J M Wierda
Journal:  J Pharmacokinet Biopharm       Date:  1999-04

2.  The rate and extent of oral bioavailability versus the rate and extent of oral absorption: clarification and recommendation of terminology.

Authors:  W L Chiou
Journal:  J Pharmacokinet Pharmacodyn       Date:  2001-02       Impact factor: 2.745

3.  Calculation of steady-state distribution delay between central and peripheral compartments in two-compartment models with infusion regimen.

Authors:  Guang Wu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2002 Oct-Dec       Impact factor: 2.441

4.  Modeling nicotine arterial-venous differences to predict arterial concentrations and input based on venous measurements: application to smokeless tobacco and nicotine gum.

Authors:  Maria Pitsiu; Jean-Michel Gries; Neal Benowitz; Steven G Gourlay; Davide Verotta
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-08       Impact factor: 2.745

5.  Dynamics of drug distribution. I. Role of the second and third curve moments.

Authors:  M Weiss; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1992-06

6.  Minimally invasive input function for 2-18F-fluoro-A-85380 brain PET studies.

Authors:  Paolo Zanotti-Fregonara; Renaud Maroy; Marie-Anne Peyronneau; Régine Trebossen; Michel Bottlaender
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-01-10       Impact factor: 9.236

7.  Relationship of apparent systemic clearance to individual organ clearances: effect of pulmonary clearance and site of drug administration and measurement.

Authors:  R Mehvar
Journal:  Pharm Res       Date:  1991-03       Impact factor: 4.200

Review 8.  Plasma radiometabolite correction in dynamic PET studies: Insights on the available modeling approaches.

Authors:  Matteo Tonietto; Gaia Rizzo; Mattia Veronese; Masahiro Fujita; Sami S Zoghbi; Paolo Zanotti-Fregonara; Alessandra Bertoldo
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-14       Impact factor: 6.200

Review 9.  Esmolol. A review of its therapeutic efficacy and pharmacokinetic characteristics.

Authors:  D Wiest
Journal:  Clin Pharmacokinet       Date:  1995-03       Impact factor: 6.447

10.  Population-based input function and image-derived input function for [¹¹C](R)-rolipram PET imaging: methodology, validation and application to the study of major depressive disorder.

Authors:  Paolo Zanotti-Fregonara; Christina S Hines; Sami S Zoghbi; Jeih-San Liow; Yi Zhang; Victor W Pike; Wayne C Drevets; Alan G Mallinger; Carlos A Zarate; Masahiro Fujita; Robert B Innis
Journal:  Neuroimage       Date:  2012-08-10       Impact factor: 6.556
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.